Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Tiziana Life Sciences Announces Registered Direct Offering for Development of Immunomodulation Therapies

Oct 31, 2024•over 1 year ago

Contract Type

partnership

LondonBiotechnologyHealth Care

Description

Tiziana Life Sciences, Ltd. announced a registered direct offering of approximately $10 million. The net proceeds from the offering will be used for the company's Phase 2a clinical trial, clinical development of foralumab in Alzheimer’s disease, developing foralumab for other indications, and for working capital and other general corporate purposes.

Company Information

Company

Tiziana Life Sciences

Location

London, England, United Kingdom

About

Tiziana Life Sciences LTD is a biotechnology company focused on transformational technology enabling alternative routes for immunotherapy .

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Tiziana Life Sciences's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.